Sat.Jul 20, 2024 - Fri.Jul 26, 2024

article thumbnail

STAT+: How UnitedHealth harnesses its physician empire to squeeze profits out of patients

STAT

UnitedHealth Group started out as a small, Minnesota health insurance company and has since morphed into a modern-day Standard Oil, exerting unmatched dominance over health care in the United States. It’s no secret that UnitedHealth is a colossus: It’s the country’s largest health insurer and the fourth-largest company of any type by revenue, just behind Apple.

article thumbnail

Discovering My Path: My Journey as a Pharmacy Student at the University of Findlay

Pharmacy Is Right For Me

Hey there, future pharmacists! I’m Shelby, a student pharmacist at the University of Findlay (UF), and I’m here to share my journey with you. If you’re thinking about a career in pharmacy or just curious about what it’s like, you’re in the right place! Falling in Love with Findlay My adventure started the summer before my senior year of high school at Findlay’s Summer Pharmacy Camp.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Citius’ first FDA decision date is approaching — and its CEO has millions on the line

PharmaVoice

Citius Pharmaceuticals CEO Leonard Mazur has personally invested $22.5 million into the company, which is fast approaching a potential turning point.

189
189
article thumbnail

Ionis plots next steps for Angelman drug Biogen passed on

BioPharma Dive

The company plans to start a late-stage study next year, after a smaller trial found its drug offered “robust and consistent” benefits on communication, cognition and motor function.

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

STAT+: Express Scripts overcharged postal workers by $45 million, audit says

STAT

Express Scripts, one of the largest pharmacy benefit managers in the country, overcharged U.S. Postal Service employees by a whopping $45 million for their prescription drugs during a recent five-year period, according to a federal audit. The findings are likely to intensify scrutiny of the controversial role played by PBMs in the opaque pharmaceutical pricing system.

article thumbnail

How NVIDIA grew with the healthcare market instead of pushing into it

Pharmaceutical Technology

As the use of AI soared across healthcare, NVIDIA fit the bill in providing the necessary technology – and its stock tells the same story.

137
137

More Trending

article thumbnail

Sanofi’s immunology bet starts to pay off

BioPharma Dive

Some analysts described Sanofi’s pipeline of immune system therapies, which includes more than half a dozen drugs in mid- to late-stage testing, as “underappreciated” by investors, as sales of Dupixent rose over the last quarter.

Immunity 115
article thumbnail

Kamala Harris, endorsed by Biden to replace him, is left of the president on health care

STAT

WASHINGTON — President Biden is ending his bid for a second term in office and backing Vice President Kamala Harris to take the nomination, he announced Sunday. While Harris shares similar views as Biden on many issues, she is to the left of the president on health care. “I believe it is in the best interest of my party and the country for me to stand down and focus solely on fulfilling my duties as president for the remainder of my term,” the president wrote in a letter sha

363
363
article thumbnail

Study suggests targeting amyloid beta production could be promising in AD

Pharma Times

The neurodegenerative disease is currently the most common cause of dementia

159
159
article thumbnail

ASCO 2024 - Matteo Levisetti

pharmaphorum

Stay updated on Matteo Levisetti, the chief medical officer at CUE Biopharma, post ASCO 2024. Learn about his latest research and contributions in the field of biopharma.

111
111
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Med List Review – Renal Concerns

Med Ed 101

In this post, I will share some questions that I would investigate from this medication list. I have many questions surrounding renal concerns given the use of sevelamer. Sevelamer is a phosphate binder that is typically used to lower phosphate levels for patients with CKD. If this patient truly has CKD and significant impairment, many […] The post Med List Review – Renal Concerns appeared first on Med Ed 101.

105
105
article thumbnail

STAT+: Jeff Shuren, medical devices head at FDA, to leave the agency

STAT

Jeffrey Shuren, longtime chief regulator of medical devices at the Food and Drug Administration, announced to staff on Tuesday that he is leaving the agency, according to six sources and an email reviewed by STAT. Shuren, who spent 28 years at the agency, started his FDA career in the Commissioner’s Office in 1998. He became director of the Center for Devices and Radiological Health in 2009 and has served in that position ever since.

363
363
article thumbnail

FDA Releases Draft Guidance on Essential Drug Delivery Outputs

FDA Law Blog: Biosimilars

By Adrienne R. Lenz, Principal Medical Device Regulation Expert — For several years, FDA has requested that sponsors of drug or biologic led combination products identify essential performance requirements (EPRs) related to the device constituent in their applications. EPRs were usually requested in the context of design controls, although 21 C.F.R. § 820.30 does not use this term.

Labelling 105
article thumbnail

HIV ‘vaccine’ could be made for just $40 a year for every patient

The Guardian - Pharmaceutical Industry

Generic version of a drug already on the market, which can suppress and prevent HIV, would still yield 30% profit if the current price was slashed, researchers say A new drug described as “the closest we have ever been to an HIV vaccine” could cost $40 (£31) a year for every patient, a thousand times less than its current price, new research suggests.

Vaccines 111
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

RCC diagnosed incident cases to reach 230,000 in 8MM by 2033: GlobalData

Express Pharma

The burden of diagnosed incident cases of renal cell carcinoma (RCC) is forecast to increase at an annual growth rate (AGR) of 1.40 per cent from around 200,000 cases in 2023 to 230,000 cases in 2033 in the eight major markets (8MM*), according to GlobalData. GlobalData’s latest report, ‘Renal Cell Carcinoma (RCC): Epidemiology Forecast to 2033’, reveals RCC cases are rising because of the longer life expectancy in those with RCC, the increasing prevalence of risk factors, the increasing inciden

105
105
article thumbnail

Opinion: To get a fair deal on Wegovy, buying Novo Nordisk might not be Medicare’s worst option

STAT

Medicare and Medicaid are facing a familiar quandary: how to provide coverage for new weight loss drugs with price tags that could effectively bankrupt the federal government’s health care budget while simultaneously ensuring continuous coverage for all other health care services used by millions of Americans. The Centers for Medicare and Medicaid Services announced in March 2024 that it would cover Wegovy (semaglutide), a new and expensive weight loss medication, for beneficiaries with c

article thumbnail

ARRS hits a high of 37,000 staff, NHS confirms

The Pharmacist

Primary care networks (PCNs) are employing 37,000 staff through the additional roles reimbursement scheme (ARRS), including pharmacists, social prescribers and physician associates, according to NHS England. A spokesperson told our sister title Pulse PCN that as of June, there were ‘37,000 roles under the programme currently in place’, which is 43% higher than their original […] The post ARRS hits a high of 37,000 staff, NHS confirms appeared first on The Pharmacist.

105
105
article thumbnail

New study shows wearable trackers provide clinical use for heart disease patients

Pharma Times

Cardiovascular disease, including coronary heart disease, currently affects around seven million people in the UK

127
127
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

SynaptixBio collaborates with Evotec to boost search for rare disease therapies

Express Pharma

SynaptixBio, a company licensed to commercialise a treatment for a rare, incurable and deadly disease, has announced its collaboration with Evotec, to find further candidate drugs to treat H-ABC, the most severe form of TUBB4A leukodystrophy. Drug research was originally carried out by the Children’s Hospital of Philadelphia (CHOP), the world’s leading centre for leukodystrophy research, under a sponsored research agreement.

Hospitals 105
article thumbnail

Bird flu that infected 6 Colorado poultry workers is closely related to the virus in cows

STAT

Bird flu snapshot: This is the latest installment in a series of regular updates on H5N1 avian flu that STAT is publishing on Monday mornings. To read future updates, you can also subscribe to STAT’s Morning Rounds newsletter. Public health experts who’ve been following the surprising spillover of H5N1 bird flu into America’s dairy cattle herds now have all eyes on Colorado, waiting to see if a cluster of human cases there might balloon into something bigger.

363
363
article thumbnail

Applying intercultural intelligence to promote growth in the Middle East

pharmaphorum

Learn how applying intercultural intelligence can promote growth and success in the dynamic and diverse business environment of the Middle East. Gain insights and strategies for effective cross-cultural communication and collaboration.

article thumbnail

BREAKING: Over 423,000 Pharmacy First consultations delivered in first three months

The Pharmacist

Some 423,310 Pharmacy First consultations were delivered in the first three months of the service, official figures from the NHS Business Service Authority (NHSBSA) have revealed. A total of 9,976 community pharmacies claimed payments for the service, although the number of those claiming on a monthly basis in February, March and April appears to be […] The post BREAKING: Over 423,000 Pharmacy First consultations delivered in first three months appeared first on The Pharmacist.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

IPC waves off TABST in Indian Pharmacopoeia

Express Pharma

The Indian Pharmacopoeia Commission (IPC) has made a progressive amendment and waived off the Target Animal Batch Safety Test (TABST) in the Indian Pharmacopoeia, effective July 1, 2024. The TABST, a non-specific safety test for veterinary vaccines, typically involves the administration of vaccine overdose to animals to test that every batch of vaccine produced is safe for a specific species.

Vaccines 105
article thumbnail

Opinion: An aging geriatrician wonders: Who will care for me?

STAT

In 1988, I became one of the first U.S. physicians certified in the new specialty of geriatric medicine, which focuses on the health care of older adults. As an idealistic and optimistic 32-year-old geriatrician, I believed that this branch of medicine would undoubtedly emerge as a vibrant field of medicine, benefiting patients and society. I was also confident that when I reached older adulthood, the health care system would be ready to care for me.

357
357
article thumbnail

Agilent builds its CDMO arm with $925m Biovectra buy

pharmaphorum

Agilent has boosted its contract development and manufacturing organisation (CDMO) capacity with a $925 million deal to buy Biovectra, a Canadian provider of fill-and-finish services and active pharmaceutical ingredients (APIs).It's a statement of intent from Agilent, whose primary business is lab instrumentation and equipment, suggesting that it intends to grow the outsourcing side of its business, which is currently focused on the production of oligonucleotide and peptide medicines.

107
107
article thumbnail

What Is Bad About Paroxetine – 3 Strikes and You’re Out

Med Ed 101

Paroxetine is from the family of SSRIs (selective serotonin reuptake inhibitors. It has been around for a long time and is indicated for depression, anxiety, and many other psychiatric indications just like other SSRIs. It doesn’t get much love from healthcare professionals. In this article, I’ll discuss what is bad about paroxetine and why we […] The post What Is Bad About Paroxetine – 3 Strikes and You’re Out appeared first on Med Ed 101.

99
article thumbnail

NewAmsterdam’s obicetrapib holds potential to become first CETP inhibitor to advance to clinical practice: GlobalData

Express Pharma

NewAmsterdam Pharma has completed the enrollment of 407 patients in the pivotal Phase III TANDEM clinical trial evaluating obicetrapib in combination with ezetimibe in patients with heterozygous familial hypercholesterolemia (HeFH) and/or atherosclerotic cardiovascular disease (ASCVD). Obicetrapib has demonstrated strong tolerability in more than 800 patients with elevated lipid levels in NewAmsterdam’s clinical trials to date.

105
105
article thumbnail

STAT+: Jiankui He, creator of CRISPR-edited children, relocates to a Chinese medical tourism hub

STAT

Jiankui He, the Chinese scientist who s parked a global uproar in 2018 when he revealed he had created the first gene-edited children , is again out on his own after being dismissed from an academic post. In January 2019, provincial health authorities found that He’s human CRISPR experiments violated national regulations against gene-editing for reproductive purposes.

357
357
article thumbnail

AZ joins call for new UK PM to back Oxford-Cambridge hub

pharmaphorum

Leading figures from industry and academia, including AstraZeneca, have urged UK PM Keir Starmer to turn the Oxford-Cambridge region into the "crown jewel" of his industrial growth plan

103
103
article thumbnail

Pharmacy bodies join calls for improved contraception access

The Pharmacist

Everyone should have access to a full range of contraceptives in ‘the location of their choosing’, an open letter signed by the National Pharmacy Association (NPA) and the Royal Pharmaceutical Society (RPS) has urged. Dr Janet Barter, secretary of the Faculty of Sexual and Reproductive Health (FSRH), wrote to secretary of state Wes Streeting this […] The post Pharmacy bodies join calls for improved contraception access appeared first on The Pharmacist.

97
article thumbnail

Budget 2024-25 prioritises R&D, education and business for MSMEs

Express Pharma

Kiran Mazumdar Shaw, Chairperson, Biocon & Biocon Biologics “The Union Budget for FY25 builds further on the government’s pre-election, Interim Budget and has positive indicators on how the government is looking at India’s economic growth and development. The FM’s emphasis on job creation through skilling is a key underlying theme. Internships at large companies with Government and CSR-backed stipends are the right approach to employability and jobs for the future.

Packaging 105
article thumbnail

At a Mass General perfusion lab, a push to make more and more hearts viable for transplant

STAT

It seems like organized chaos. Five lab members move around a room the size of a galley kitchen. On this day, three high school students also squeeze into the medical lab, closely peering at a pig heart barely beating in a box. Tubes connected to the heart from a rhythmic, speaker-like pump push warm red blood cells through its chambers. It looks like a scene out of Frankenstein.

363
363